The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Multifocal motor neuropathy improved by IVIg: Randomized, double-blind, placebo-controlled study
Abstract
OBJECTIVE: To determine the effect of IV immunoglobulin (IVIg) on neurologic function and electrophysiologic studies in multifocal motor neuropathy with conduction block (MMN). BACKGROUND: MMN is characterized by progressive, asymmetric, lower motor neuron weakness and is probably immune-mediated. IVIg treatment has been shown to have beneficial effects in several open-label studies and in one small controlled trial. However, larger randomized controlled studies are lacking. METHODS: The authors recruited 16 patients with MMN. All subjects were given each of two treatments (IVIg [0.4 g/kg/d for 5 consecutive days] or placebo [dextrose or saline]) that were assigned according to a randomized, crossover design under double-blind conditions. Patients were evaluated before and about 28 days after trial treatment for subjective functional improvement, neurologic disability score, grip strength, distal and proximal compound muscle action potential amplitude, and conduction block. RESULTS: Subjective functional improvement with IVIg treatment was rated as dramatic or very good in nine patients, moderate in one, mild in one, and absent in five patients. This improvement was absent after placebo. The neurologic disability score improved by 6.7+/-3.3 points with IVIg treatment, whereas it decreased by 2.1+/-3.0 with placebo (p = 0.038). Grip strength on the weaker side was increased by 6.4+/-1.9 kg with IVIg treatment; it decreased by 1.0+/-0.8 kg with placebo (p = 0.0021). Conduction block worsened by 12.98+/-6.52 % with placebo, but improved by 12.68+/-5.62 % with IVIg treatment (p = 0.037). Conduction block was reversed in five patients with IVIg but not placebo. CONCLUSION: IVIg improved conduction block as well as subjective and objective clinical measures of function in patients with MMN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
Pestronk, A., Cornblath, D. R., Ilyas, A. A., Baba, H., Quarles, R. H., Griffin, J. W., Alderson, K., & Adams, R. N. (1988) · Annals of Neurology · doi:10.1002/ana.410240113 · Cited by 609
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment
Dyck, P. J., O'Brien, P. C., Oviatt, K. F., Dinapoli, R. P., Daube, J. R., Bartleson, J. D., Mokri, B., Swift, T., Low, P. A., & Windebank, A. J. (1982) · Annals of Neurology · doi:10.1002/ana.410110205 · Cited by 483
Hahn, A. F., Bolton, C. F., Pillay, N., Chalk, C., Benstead, T. J., Bril, V., Shumak, K. H., Vandervoort, M. K., & Feasby, T. E. (1996) · Brain · doi:10.1093/brain/119.4.1055 · Cited by 409
Self-citationInternodal conduction in undissected demyelinated nerve fibres
Rasminsky, M., & Sears, T. A. (1972) · The Journal of Physiology · doi:10.1113/jphysiol.1972.sp010035 · Cited by 329
Multifocal acquired demyelinating neuropathy masqurading as motor neuron disease
Parry, G. J., & Clarke, S. (1988) · Muscle & Nerve · doi:10.1002/mus.880110203 · Cited by 286
Van den Berg, L. H., Kerkhoff, H., Oey, P. L., Franssen, H., Mollee, I., Vermeulen, M., Jennekens, F. G., & Wokke, J. H. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.3.248 · Cited by 254
Pestronk, A., Chaudhry, V., Feldman, E. L., Griffin, J. W., Cornblath, D. R., Denys, E. H., Glasberg, M., Kuncl, R. W., Olney, R. K., & Yee, W. C. (1990) · Annals of Neurology · doi:10.1002/ana.410270314 · Cited by 230
Multifocal motor neuropathy: Response to human immune globulin
Chaudhry, V., Corse, A. M., Cornblath, D. R., Kuncl, R. W., Drachman, D. B., Freimer, M. L., Miller, R. G., & Griffin, J. W. (1993) · Annals of Neurology · doi:10.1002/ana.410330303 · Cited by 218
The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy
van den Berg, L. H. (1998) · Brain · doi:10.1093/brain/121.3.421 · Cited by 106
Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera
Adams, D., Küntzer, T., Burger, D., et al. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90192-a · Cited by 94
Cited by
ORANGE, J., HOSSNY, E., WEILER, C., BALLOW, M., BERGER, M., BONILLA, F., BUCKLEY, R., CHINEN, J., ELGAMAL, Y., & MAZER, B. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.015 · Cited by 653
Joint Task Force of the EFNS and the PNS (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00290.x · Cited by 568
Chronic Inflammatory Demyelinating Polyneuropathy
Köller, H., Kieseier, B. C., Jander, S., & Hartung, H.-P. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041347 · Cited by 511
Clinical uses of intravenous immunoglobulin
Jolles, S., Sewell, W. A. C., & Misbah, S. A. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02834.x · Cited by 374
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
Dalakas, M. C. (2004) · JAMA · doi:10.1001/jama.291.19.2367 · Cited by 329
Metadata
- Authors
- Federico, P., Zochodne, D. W., Hahn, A. F., Brown, W. F., & Feasby, T. E.
- Venue
- Neurology
- Published
- 2000-11-14
- Volume
- 55
- Issue
- 9
- Pages
- 1256-1262
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2121894749
- Cited by
- 263
- References
- 16
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multifocal motor neuropathy improved by IVIg: Randomized, double-blind, placebo-controlled study. https://app.cochat.ai/papers/10.1212/wnl.55.9.1256
- The paper
- Federico, P., Zochodne, D. W., Hahn, A. F., Brown, W. F., & Feasby, T. E. (2000). Multifocal motor neuropathy improved by IVIg: Randomized, double-blind, placebo-controlled study. Neurology. https://doi.org/10.1212/wnl.55.9.1256
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.